Subcutaneous interferon alfa for the treatment of cutaneous pseudolymphoma.
Department of Dermatology, Duke University Medical Center, Durham, NC 27710, USA.
Holly Leigh
HL
Singletary
M Angelica
MA
Selim
Elise
E
Olsen
D000328:Adult; D001706:Biopsy; D003937:Diagnosis, Differential; D005260:Female; D005434:Flow Cytometry; D005500:Follow-Up Studies; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use; D007279:Injections, Subcutaneous; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000627:therapeutic use; D019310:Pseudolymphoma / Q000175:diagnosis / Q000188:drug therapy*; D012871:Skin Diseases / Q000175:diagnosis / Q000188:drug therapy*
D007155:Immunologic Factors; D016898:Interferon-alpha